Login / Signup

Long-term outcomes in COVID-19 patients who recovered from the first wave of the pandemic.

Dan CuiSimiao ChenLuzhao FengMengmeng JiaYeming WangWeijun XiaoYanxia SunQiangru HuangLibing MaZhiwei LengHao WangBin CaoWeizhong YangJuntao YangChen Wang
Published in: National science review (2022)
This cross-sectional study evaluated the long-term health effects of coronavirus disease 2019 (COVID-19) in Jianghan District (Wuhan, China). The results showed that 61.4% of COVID-19 patients reported at least one symptom and 8.8% had depressive symptoms at the 17-month follow-up. The proportion of patients with chest radiographic abnormalities in Fangcang shelter hospitals and designated COVID-19 hospitals was 31.6% and 41.1%, respectively, and the proportion of patients with impaired pulmonary diffusion capacity in these hospitals was 52.8% and 60.9%, respectively. Female sex (odds ratio [OR] = 1.48, 95% confidence interval [CI]: 1.16-1.88), severe disease (OR = 1.46, 95% CI: 1.01-2.10) and a higher number of initial symptoms (OR = 1.31, 95% CI: 1.23-1.40) were associated with the development of sequelae symptoms at 17 months. This study involving community-dwelling COVID-19 adults may help determine the long-term effects of COVID-19 during the first pandemic wave. Nonetheless, larger follow-up studies are needed to characterize the post-COVID-19 condition.
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • depressive symptoms
  • healthcare
  • community dwelling
  • pulmonary hypertension
  • south africa
  • sleep quality
  • early onset
  • drug induced